ConductScience.org, home

Comparison · NCT01106833-deaths

Sirolimus, Calcineurin Inhibitor, and Prednisone vs Sirolimus and Prednisone: deaths from any cause

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Sirolimus, Calcineurin Inhibitor, and Prednisone vs Sirolimus and Prednisone: deaths from any cause. Trial comparisons, record NCT01106833-deaths. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01106833-deaths

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.2420.1550.358wilson
Risk in group 20.1810.1090.285wilson
Risk difference, group 1 minus group 20.0619-0.07410.198newcombe hybrid score
Risk ratio, group 1 over group 21.340.72.57log
Odds ratio, group 1 over group 21.450.6383.31log
Number needed to harm, for one more death from any cause on Sirolimus, Calcineurin Inhibitor, and Prednisone than on Sirolimus and Prednisone16.2from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Sirolimus, Calcineurin Inhibitor, and Prednisone
Sirolimus + calcineurin inhibitor + prednisone~Sirolimus + calcineurin inhibitor + prednisone: The target serum level for sirolimus is 3-12 ng/mL.~The target serum level for tacrolimus is 5-10 ng/mL. The target serum level for cyclosporine is 120-200 ng/mL.~Prednisone is administered initially as a single early morning dose of 1 mg/kg/day (or equivalent). If prednisone at a dose of 1 mg/kg/day (or equivalent) is contraindicated, patients may begin prednisone between 0.5-1 mg/kg/day.
1666EG000
Group 2Sirolimus and Prednisone
Sirolimus + prednisone~Sirolimus + prednisone: The target serum level for sirolimus is 3-12 ng/mL.~Prednisone is administered initially as a single early morning dose of 1 mg/kg/day (or equivalent). If prednisone at a dose of 1 mg/kg/day (or equivalent) is contraindicated, patients may begin prednisone between 0.5-1 mg/kg/day.
1372EG001

Harm

What it counts
Total, all-cause mortality
Time frame
Three years post-randomization

Source ClinicalTrials.gov

Trial

Title
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
NCT number
NCT01106833
Phases
PHASE2, PHASE3
Conditions
Chronic GVHD
Interventions
Sirolimus + calcineurin inhibitor + prednisone, Sirolimus + prednisone
Lead sponsor
Medical College of Wisconsin
Results first posted
2018-08-14

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT01106833-deaths